Anest. intenziv. Med. 2016;27(2):71-74

Malignant hyperthermiaAnaesthesiology - Review articles

T. Vymazal
Klinika anesteziologie, resuscitace a intenzivní medicíny, 2. LF UK a FN v Motole, Praha

Malignant hyperthermia is a rare, life-threatening condition, usually triggered by exposure to certain drugs used for general anaesthesia - specifically volatile anaesthetics (halothane, isoflurane, sevoflurane) and neuromuscular blocking agents (esp. suxamethonium). In susceptible individuals, these drugs can induce a drastic and uncontrolled increase in oxidative metabolism in the skeletal muscle leading to muscle rigidity, which overwhelms the body's capacity to supply oxygen, remove carbon dioxide and regulate body temperature, eventually leading to circulatory collapse and death if not immediately treated. This review article brings information about the pathophysiology, symptoms, treatment and prevention of malignant hyperthermia for a wide range of clinicians.

Keywords: malignant hyperthermia; general anaesthesia

Received: October 29, 2015; Accepted: January 2, 2016; Published: April 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vymazal T. Malignant hyperthermia. Anest. intenziv. Med. 2016;27(2):71-74.
Download citation

References

  1. Harrison's Principles of Internal Medicine. 2008, p. 18, 419-20.
  2. Civetta, Taylor & Kirby's Critical Care. 2009, p. 1100-1101, 1331-1334.
  3. David E: Longnecker. Anestesiology. 2008. p. 1964-1984.
  4. Johannsen, S., Treves, S., Müller, C. R., Mögele, S., Schneiderbanger, D., Roewer, N., Schuster, F. Functional characterization of the RYR1 mutation p.Arg4737Trp associated with susceptibility to malignant hyperthermia. Neuromuscul. Disord., 2015, Nov 11. pii: S0960-8966(15)00770-1. doi: 10.1016/j.nmd.2015.11.001. [Epub ahead of print]. Go to original source... Go to PubMed...
  5. Miyamoto, Y., Miyashita, T., Takaki, S., Goto, T. Perioperative considerations in adult mitochondrial disease: A case series and a review of 111 cases. Mitochondrion., 2015, Nov 19, 26, p. 26-32. Go to original source... Go to PubMed...
  6. Campion, G. H., Hadi, A. S., Berman, A. J., Hoffman, R. S. Questions regarding the diagnosis of malignant hyperthermia. Anesthesiology, 2015, 123, 3, p. 731-732. doi: 10.1097/ALN.0000000000000760. Go to original source... Go to PubMed...
  7. Petersen, B., Busch, T., Meinecke, C. D., Börge, B., Kluba, K., Kaisers, U. X., Rüffert, H. Telephone enquiries on the topic of malignant hyperthermia : Evaluation of the content and subsequent diagnostic results at the MH Center Leipzig. Anaesthesist, 2015, Oct 19. [Epub ahead of print].
  8. Isaak, R. S., Stiegler, M. P. Review of crisis resource management (CRM) principles in the setting of intraoperative malignant hyperthermia. J. Anesth., 2015, Dec 17. [Epub ahead of print]. Go to original source... Go to PubMed...
  9. Lu, Z., Rosenberg, H., Brady, J. E., Li, G. Prevalence of Malignant Hyperthermia Diagnosis in New York State Ambulatory Surgery Center Discharge Records 2002 to 2011. Anesth. Analg. 2015, Nov 9. [Epub ahead of print]. Go to original source... Go to PubMed...
  10. http://www.mhaus.org/
  11. http://www.hypertermie.estranky.cz/
  12. http://www.mhinfo.cz/info/




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.